Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis
نویسندگان: خسرو ادیب کیا , محمد رضا سیاهی شادباد , علی نخودچی , علیرضا جوادزاده , محمد برزگر جلالی , ژاله برار , یداله امیدی
کلمات کلیدی: Endotoxin-induced uveitis, EudragitwRS100, nanomedicines, nanotechnology, piroxicam, ocular delivery systems
نشریه: 17392 , 5 , 15 , 2008
| نویسنده ثبت کننده مقاله |
یداله امیدی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات ریز فناوری دارویی |
| کد مقاله |
74164 |
| عنوان فارسی مقاله |
Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis |
| عنوان لاتین مقاله |
Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح دو – PubMed |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| To investigate the anti-inflammatory impacts of piroxicam nanosuspension, in the current investigation, piroxicam:EudragitwRS100 nanoformulations were used to control inflammatory symptoms in the rabbits with endotoxin-induced uveitis (EIU).
The nanoparticles of piroxicam:EudragitwRS100 was formulated using the solvent evaporation/extraction technique. The
morphological and physicochemical characteristics of nanoparticles were studied using particle size analysis, X-ray
crystallography, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and scanning
electron microscopy (SEM). Drug release profiles were examined by fitting the data to the most common kinetic models. Selected
nanosuspensions were used to assess the anti-inflammatory impacts of piroxicam nanoparticles in the rabbits with EIU. The major
symptoms of EIU (i.e. inflammation and leukocytes numbers in the aqueous humor) were examined. All the prepared piroxicam
formulations using EudragitwRS100 resulted in a nano-range size particles and displayed spherical smooth morphology with
positively charged surface, however, the formulated particles of drug alone using same methodology failed to manifest such
characteristics. The EudragitwRS100 containing nanoparticles displayed lower crystallinity than piroxicam with no chemical
interactions between the drug and polymer molecules. Kinetically, the release profiles of piroxicam from nanoparticles appeared to
fit best with the Weibull model and diffusion was the superior phenomenon. The in vivo examinations revealed that the
inflammation can be inhibited by the drug:polymer nanosuspension more significantly than the microsuspension of drug alone in
the rabbits with EIU. Upon these findings, we propose that the piroxicam:EudragitwRS100 nanosuspensions may beconsidered as
an improved ocular delivery system for locally inhibition of inflammation. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Piroxicam nanoparticles for ocular delivery.pdf | 1399/07/27 | 416540 | دانلود |